Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Treatment With Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT): A Multicenter, Randomized, Placebo-controlled, Clinical Trial

NCT06548971 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT06548971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06548971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Treatment With Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT): A Multicenter, Randomized, Placebo-controlled, Clinical Trial
Lead sponsor
Capital Medical University
Phase
Phase 3
Overall status
Recruiting
Start date
November 7, 2024
Completion date
December 31, 2027
Enrollment
1,184 (estimated)
Sites
119

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, cerebral infarction